Small Molecules
14 June 2017
Phase 2a Safety and Efficacy Data Support Further Development of Oral CC-220 in Patients with Lupus14 June 2017
ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug12 June 2017
Alkermes Announces Initiation of Study 217 for ALKS 5461 for Treatment of Major Depressive Disorder12 June 2017
Foamix Announces Dosing of First Patient in Phase 3 Rosacea Clinical Trials for FMX103 Minocycline Foam 1.5%News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports